Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Targeting Lymphoma Associated Myeloid-Monocytic Cells through CSF1R Blockade Enhances CAR-T Cell Response in Aggressive B Cell Lymphoma

Blood (2024) 144 (Supplement 1): 367.

https://doi.org/10.1182/blood-2024-203291

Published: 2024

Journal Articles

CSF1R Targeting T Cell Engaging Bispecific Antibodies Enable Safe and Efficient Immunotherapies in Acute Myeloid Leukemia

Gordon Victor Hoffmann, Adrian Gottschlich, Johannes Sam, Samuel Gebhardt, Lisa Rohrbacher, Sayantan Nandi, Emanuele Carlini, Tobias Herold, Michael von Bergwelt-Baildon, Stefan Endres, Marion Subklewe, Peter Bruenker, Christian Klein, Sebastian Kobold

Blood (2024) 144 (Supplement 1): 918.

https://doi.org/10.1182/blood-2024-207376

Published: 2024

Journal Articles

Dissection of Single-Cell Landscapes for the Development of Chimeric Antigen Receptor T Cells in Hodgkin Lymphoma

Blood (2024) 144 (Supplement 1): 4796.

https://doi.org/10.1182/blood-2024-207274

Published: 2024

Journal Articles

Giving T-cell bispecifics a helping hand

Sebastian Kobold

Blood (2024) 143 (21): 2115–2116.

https://doi.org/10.1182/blood.2024024346

Published: 2024

Journal Articles

Two Players, One Goal: BiTE ® Vs CART Targeting FLT3 in AML

Lisa Rohrbacher, Daniel Nixdorf, Helena Stadler, Bettina Brauchle, Florian Märkl, Nora Philipp, Gerulf Hänel, Anetta Marcinek, Maryam Kazerani, Alica Joana Emhardt, Giulia Magno, Rebecca L. Goldstein, Tobias Straub, Sebastian Kobold, Tara L. Chapman-Arvedson, Veit L. Buecklein, Marion Subklewe

Blood (2023) 142 (Supplement 1): 3444.

https://doi.org/10.1182/blood-2023-177922

Published: 2023

Journal Articles

CD33-TIM3 Dual CAR T Cells: Enhancing Specificity While Maintaining Efficacy Against AML

Yingshuai Wang, Wenjie Lu, Lisa Rohrbacher, Heinrich Flaswinkel, Alica Joana Emhardt, Giulia Magno, Sascha Haubner, Sebastian Kobold, Heinrich Leonhardt, Karl-Peter Hopfner, Dirk H Busch, Veit L. Buecklein, Daniel Nixdorf, Marion Subklewe

Blood (2023) 142 (Supplement 1): 3449.

https://doi.org/10.1182/blood-2023-180890

Published: 2023

Journal Articles

Adaptor Anti-P329G CAR T Cells for Modular Targeting of AML

Sophia Stock, Thaddaeus Strzalkowski, Adrian Gottschlich, Lisa Rohrbacher, Luisa Fertig, Vivien D. Menkhoff, Marlena Surowka, Peter Bruenker, Diana Darowski, Stefan Endres, Michael von Bergwelt-Baildon, Marion Subklewe, Christian Klein, Sebastian Kobold

Blood (2023) 142 (Supplement 1): 4805.

https://doi.org/10.1182/blood-2023-182864

Published: 2023

Journal Articles

The Race Is on: BiTE Vs CART As FLT3-Directed Immunotherapies in AML

Lisa Rohrbacher, Daniel Nixdorf, Helena Stadler, Bettina Brauchle, Florian Märkl, Nora Phillip, Gerulf Hänel, Anetta Marcinek, Maryam Kazerani, Rebecca Goldstein, Michael von Bergwelt, Sebastian Kobold, Veit L Buecklein, Tara Chapman-Arvedson, Marion Subklewe

Blood (2022) 140 (Supplement 1): 10233–10234.

https://doi.org/10.1182/blood-2022-158452

Published: 2022

Journal Articles

Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR

Dana Stenger, Tanja A. Stief, Theresa Kaeuferle, Semjon Willier, Felicitas Rataj, Kilian Schober, Binje Vick, Ramin Lotfi, Beate Wagner, Thomas G. P. Grünewald, Sebastian Kobold, Dirk H. Busch, Irmela Jeremias, Franziska Blaeschke, Tobias Feuchtinger

Blood (2020) 136 (12): 1407–1418.

https://doi.org/10.1182/blood.2020005185

Published: 2020

Includes: Supplemental data

Journal Articles

Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia

Monika Herrmann, Christina Krupka, Katrin Deiser, Bettina Brauchle, Anetta Marcinek, Ana Ogrinc Wagner, Felicitas Rataj, Ralph Mocikat, Klaus H. Metzeler, Karsten Spiekermann, Sebastian Kobold, Nadja C. Fenn, Karl-Peter Hopfner, Marion Subklewe

Blood (2018) 132 (23): 2484–2494.

https://doi.org/10.1182/blood-2018-05-849802

Published: 2018

Includes: Supplemental data

Journal Articles

Development of a Bifunctional Checkpoint Inhibitory T Cell Engager (CiTE) to Reverse Adaptive Immune Escape in AML

Monika Herrmann, PhD, Christina Krupka, PhD, Katrin Deiser, PhD, Bettina Lindl, Ralph Mocikat, MD, Klaus H. Metzeler, MD, Karsten Spiekermann, MD, Sebastian Kobold, MD, Nadja Fenn, PhD, Karl-Peter Hopfner, PhD, Marion Subklewe, MD

Blood (2018) 132 (Supplement 1): 4069.

https://doi.org/10.1182/blood-2018-99-119624

Published: 2018

Journal Articles

Virus-associated activation of innate immunity induces rapid disruption of Peyer’s patches in mice

Simon Heidegger, David Anz, Nicolas Stephan, Bernadette Bohn, Tina Herbst, Wolfgang Peter Fendler, Nina Suhartha, Nadja Sandholzer, Sebastian Kobold, Christian Hotz, Katharina Eisenächer, Susanne Radtke-Schuller, Stefan Endres, Carole Bourquin

Blood (2013) 122 (15): 2591–2599.

https://doi.org/10.1182/blood-2013-01-479311

Published: 2013

Includes: Supplemental data

Journal Articles

Analysis of Spontaneous Vs. Vaccine-Induced Antibody Responses Against Cancer-Testis Antigen MAGE-A3 in Cancer Patients

Yanran Cao, M.D., Sacha Gnjatic, Ph.D., Vincent G. Brichard, M.D. Ph.D., Tim Luetkens, M.D., Sebastian Kobold, M.D., Katrin Bartels, Nasser Altorki, M.D., Friedrich Haag, M.D., Gerd Ritter, M.D., Carsten Bokemeyer, M.D., Lloyd J Old, M.D., Nicolaus Kroeger, M.D., Djordje Atanackovic, M.D.

Blood (2011) 118 (21): 5087.

https://doi.org/10.1182/blood.V118.21.5087.5087

Published: 2011

Journal Articles

Strong Antibody Responses Against a Unique Region of CT-Antigen SSX-2 Are Induced After Allogeneic Stem Cell Transplantation and Correlate with Clinical Remission In Patients with Multiple Myeloma

Sebastian Kobold, Tim Luetkens, Yanran Cao, Corinna Eberhardt, Sinje Tams, Britta Marlen Bartels, Katrin Bartels, Sabrina Meyer, Friedrich Haag, Carsten Bokemeyer, Axel R. Zander, MD, Nicolaus Kröger, Djordje Atanackovic

Blood (2010) 116 (21): 1900.

https://doi.org/10.1182/blood.V116.21.1900.1900

Published: 2010

Journal Articles

Longitudinal and Functional Analysis of Spontaneous NY-ESO-1-Specific Antibody Responses in Multiple Myeloma Patients.

Sebastian Kobold, MD, Yanran Cao, MD, Sinje Tams, Britta Marlen Bartels, Tim Lütkens, Caroline Pabst, Andreas Marx, Friedrich Haag, Carsten Bokemeyer, MD, Nikolaus Kroeger, MD, Djordje Atanackovic, M.D.

Blood (2009) 114 (22): 2831.

https://doi.org/10.1182/blood.V114.22.2831.2831

Published: 2009

Journal Articles

A Characteristic Cytokine/Chemokine Milieu Is Present in the Bone Marrow Environment of Multiple Myeloma Patients Before and After Allogeneic Stem Cell Transplantation.

Yanran Cao, MD, Tim Luetkens, MD, Sebastian Kobold, MD, York Hildebrandt, Maja Gordic, Nesrine Lajmi, Sabrina Meyer, Katrin Bartels, Axel R. Zander, MD, Carsten Bokemeyer, MD, Nicolaus Kröger, MD, Djordje Atanckovic, MD

Blood (2009) 114 (22): 2795.

https://doi.org/10.1182/blood.V114.22.2795.2795

Published: 2009

NARROW

Targeting Lymphoma Associated Myeloid-Monocytic Cells through CSF1R Blockade Enhances CAR-T Cell Response in Aggressive B Cell Lymphoma

CSF1R Targeting T Cell Engaging Bispecific Antibodies Enable Safe and Efficient Immunotherapies in Acute Myeloid Leukemia

Dissection of Single-Cell Landscapes for the Development of Chimeric Antigen Receptor T Cells in Hodgkin Lymphoma

Giving T-cell bispecifics a helping hand

Two Players, One Goal: BiTE ® Vs CART Targeting FLT3 in AML

CD33-TIM3 Dual CAR T Cells: Enhancing Specificity While Maintaining Efficacy Against AML

Adaptor Anti-P329G CAR T Cells for Modular Targeting of AML

The Race Is on: BiTE Vs CART As FLT3-Directed Immunotherapies in AML

Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR

Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia

Development of a Bifunctional Checkpoint Inhibitory T Cell Engager (CiTE) to Reverse Adaptive Immune Escape in AML

Virus-associated activation of innate immunity induces rapid disruption of Peyer’s patches in mice

Analysis of Spontaneous Vs. Vaccine-Induced Antibody Responses Against Cancer-Testis Antigen MAGE-A3 in Cancer Patients

Strong Antibody Responses Against a Unique Region of CT-Antigen SSX-2 Are Induced After Allogeneic Stem Cell Transplantation and Correlate with Clinical Remission In Patients with Multiple Myeloma

Longitudinal and Functional Analysis of Spontaneous NY-ESO-1-Specific Antibody Responses in Multiple Myeloma Patients.

A Characteristic Cytokine/Chemokine Milieu Is Present in the Bone Marrow Environment of Multiple Myeloma Patients Before and After Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only